Suarez, C., Motzer, R. J., Powles, T., Bourlon, M. T., Tomita, Y., George, S., Kessler, E. R., Bedke, J., Escudier, B., Apolo, A. B., Burotto, M., Zhang, J., Williamson, D. S., Andrianova, L., Perez, J. R., Hall, T. D., Choueiri, T. K., Shah, A. Y. (2026). Characterization of depth and durability of response in patients (pts) with previously untreated advanced renal cell carcinoma (aRCC) who received cabozantinib plus nivolumab (C+N): Long-term follow-up and exploratory analysis of CheckMate 9ER.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.508